Credit: Geoff Burke-USA TODAY Sports

Washington Redskins Injury Report Analysis - Week 17

Washington Redskins Injury Report analysis – Week 17

Ryan Kerrigan – OLB – Wrist –  ProbableKerrigan has been coming on the last two games with two sacks against the Atlanta Falcons and the Dallas Cowboys.  With his counterpart Brian Orakpo struggling with an injury as well this week, it’s almost imperative that Kerrigan is available because he’s the Redskins second leading pass rusher.  However, it appears as though Kerrigan’s wrist injury will not prevent him playing this week against the New York Giants, as he’s listed as probable.

Brian Orakpo – OLB – Groin – Questionable Orakpo has been on a tear in the second half of the season from a pass rushing stand point, and now has 10 sacks on the season.  But he suffered a groin injury late in the game last week against the Dallas Cowboys and he may be unable to go this week against the Giants as he’s listed as questionable.  If Orakpo can’t go then the Redskins will turn to backup Rob Jackson, who has played well at times in the past when Orakpo has been injured.  Jackson isn’t the pass rusher that Orakpo is, but is very good in coverage.

Darrell Young – FB – Hamstring – Probable  We’ve seen what happens to the Redskins running game when Young isn’t in the lineup.  Running back Alfred Morris had his worst stretch of the season when Young was out due to this hamstring injury.  Not having Young in the lineup will hurt the Redskins rushing attack, and he’s also a decent receiver, and very good in short yardage situations.  However, Young played last week against the Cowboys, and he is listed as probable this week, and will play against the Giants.

Redskins Injury Report – Week 17

  • Redskins inside linebacker Nick Barnett suffered a torn MCL against the Cowboys and is out for the season, having been placed on injured reserve.

Next Redskins Game Full schedule »
Monday, Oct 2727 Oct7:30at Dallas CowboysBuy Tickets

Tags: Brian Orakpo Redskins Injury Report Washington Redskins

comments powered by Disqus